Home LiteratureArticle Details
PMID: 9202067 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

The Journal of clinical investigation ·Vol. 100 ·No. 1 ·1997-07-01 ·Pages 149-57

Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV

Abstract

Decorin belongs to a family of secreted, small, leucine-rich proteoglycans that affect matrix assembly and cellular growth. Ectopic expression of decorin proteoglycan or protein core as a mutated form lacking any glycosaminoglycan side chains induced growth suppression in neoplastic cells of various histogenetic origins, including tumor cells derived from gastrointestinal, genital, skeletal, cutaneous, or bone marrow tissues. Exogenously added recombinant decorin also suppressed overall growth of the parental cell lines. In all stably-transfected clones, growth retardation was specifically associated with induction of the potent cyclin-dependent kinase inhibitor p21, but not p27, and subsequent translocation of p21 protein into the nuclei of decorin-expressing cells. This led to a greater proportion of the cells arrested in G1 phase of the cell cycle. These changes were independent of functional p53 or retinoblastoma protein. De novo expression of decorin in HCT116 human colon carcinoma cells harboring a disrupted p21 gene failed to induce growth suppression, in contrast to the wild-type cells in which p21 and growth arrest could be induced. These findings indicate that ectopic production of decorin protein core can retard the growth of a variety of tumor cells and that endogenous p21 is a required downstream effector of this biological axis.

MeSH Terms
Animals CHO Cells Cell Cycle Proteins Cell Division/drug effects,physiology Cell Line Cricetinae Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases/antagonists & inhibitors Cyclins/biosynthesis Cytomegalovirus Decorin Enzyme Inhibitors/metabolism Extracellular Matrix Proteins Genetic Vectors HeLa Cells Humans Kinetics Lung Microtubule-Associated Proteins/biosynthesis Proteoglycans/biosynthesis,pharmacology Recombinant Proteins/biosynthesis,pharmacology Skin Transfection Tumor Cells, Cultured Tumor Suppressor Proteins
Chemicals
CDKN1A protein, human Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p21 Cyclins DCN protein, human Decorin Enzyme Inhibitors Extracellular Matrix Proteins Microtubule-Associated Proteins Proteoglycans Recombinant Proteins Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Santra M
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Mann D M
Mercer E W
Skorski T
Calabretta B
Iozzo R V
References (42)
42 references, click to expand
  1. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas.
    Oncogene Res. 1989;4(3):205-14 PMID: 2740144
  2. Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation.
    Nature. 1988 Nov 17;336(6196):244-6 PMID: 3194009
  3. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia.
    Leuk Res. 1990;14(5):417-22 PMID: 2140591
  4. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels.
    J Biol Chem. 1990 Jul 5;265(19):11389-96 PMID: 2162845
  5. Negative regulation of transforming growth factor-beta by the proteoglycan decorin.
    Nature. 1990 Jul 19;346(6281):281-4 PMID: 2374594
  6. Proteoglycans as modulators of growth factor activities.
    Cell. 1991 Mar 8;64(5):867-9 PMID: 2001586
  7. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
    Nature. 1992 Nov 26;360(6402):361-4 PMID: 1280332
  8. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.
    J Immunol Methods. 1993 Jan 4;157(1-2):233-40 PMID: 8423368
  9. Altered proteoglycan gene expression and the tumor stroma.
    Experientia. 1993 May 15;49(5):447-55 PMID: 8500599
  10. Preferential gene expression in quiescent human lung fibroblasts.
    Cell Growth Differ. 1993 Jun;4(6):483-93 PMID: 8396966
  11. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  12. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  13. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    Cancer Res. 1994 Mar 1;54(5):1169-74 PMID: 8118801
  14. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
    Nature. 1994 Jun 16;369(6481):574-8 PMID: 7911228
  15. Induction of WAF1/CIP1 by a p53-independent pathway.
    Cancer Res. 1994 Jul 1;54(13):3391-5 PMID: 8012956
  16. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  17. Induction of p21 (WAF-1/CIP1) during differentiation.
    Oncogene. 1994 Nov;9(11):3389-96 PMID: 7936667
  18. The murine decorin. Complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation.
    J Biol Chem. 1994 Nov 11;269(45):28270-81 PMID: 7961765
  19. Principles of CDK regulation.
    Nature. 1995 Mar 9;374(6518):131-4 PMID: 7877684
  20. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.
    J Clin Invest. 1995 Mar;95(3):973-9 PMID: 7883998
  21. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha.
    J Biol Chem. 1995 May 12;270(19):11692-700 PMID: 7744809
  22. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells.
    Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7016-20 PMID: 7624361
  23. Inhibition of cyclin-dependent kinases by p21.
    Mol Biol Cell. 1995 Apr;6(4):387-400 PMID: 7626805
  24. Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue.
    Lab Invest. 1995 Aug;73(2):157-60 PMID: 7637316
  25. Cyclins, CDKs and cancer.
    Semin Cancer Biol. 1995 Apr;6(2):63-72 PMID: 7647308
  26. p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
    Cancer Res. 1995 Nov 15;55(22):5187-90 PMID: 7585571
  27. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.
    Nat Med. 1996 Apr;2(4):418-23 PMID: 8597951
  28. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function.
    FASEB J. 1996 Apr;10(5):598-614 PMID: 8621059
  29. A role for activated p21 ras in inhibition/regulation of platelet-derived growth factor (PDGF) type-beta receptor activation.
    Oncogene. 1996 Mar 21;12(6):1213-22 PMID: 8649823
  30. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21.
    Nature. 1996 Jun 20;381(6584):713-6 PMID: 8649519
  31. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases.
    J Biol Chem. 1996 Aug 2;271(31):18961-5 PMID: 8702560
  32. Genetic determinants of p53-induced apoptosis and growth arrest.
    Genes Dev. 1996 Aug 1;10(15):1945-52 PMID: 8756351
  33. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.
    Cell Growth Differ. 1996 Jul;7(7):893-901 PMID: 8809407
  34. Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen.
    Cell Growth Differ. 1996 Oct;7(10):1353-60 PMID: 8891339
  35. Model structure of decorin and implications for collagen fibrillogenesis.
    J Biol Chem. 1996 Dec 13;271(50):31767-70 PMID: 8943211
  36. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors.
    Cell. 1996 Dec 13;87(6):1069-78 PMID: 8978611
  37. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.
    J Cell Biol. 1997 Feb 10;136(3):729-43 PMID: 9024701
  38. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.
    Crit Rev Biochem Mol Biol. 1997;32(2):141-74 PMID: 9145286
  39. Neoplastic modulation of extracellular matrix. Colon carcinoma cells release polypeptides that alter proteoglycan metabolism in colon fibroblasts.
    J Biol Chem. 1985 Jun 25;260(12):7464-73 PMID: 3997882
  40. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.
    Proc Natl Acad Sci U S A. 1986 Oct;83(20):7683-7 PMID: 3484330
  41. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro.
    Coll Relat Res. 1987 Jun;7(2):105-14 PMID: 3621881
  42. Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis.
    J Biol Chem. 1990 Mar 25;265(9):5317-23 PMID: 2108171
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1997-07-01
Pages
149-57
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508175
Subset
IM
Grants
NCI NIH HHS · R01 CA39481 · United States
NCI NIH HHS · R01 CA46782 · United States
NCI NIH HHS · R01 CA47282 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com